On July 20, 2021, the Board of Directors of Emergent BioSolutions Inc. (the “Company”) approved a proposal made by the Chief Executive Officer to reorganize the responsibilities of members of the executive management team reporting to the Chief Executive Officer. In connection with that reorganization, Adam Havey’s role is expanded to Executive Vice President and Chief Operating Officer of the Company. This reorganization and Mr. Havey’s appointment as the Company’s principal operating officer are effective as of July 26, 2021.